Morocco - Healthcare, Regulatory and Reimbursement Landscape

Published : Nov-2021

No. of Pages : 140

order by fax Inquire before Buying request discount

1 Table of Contents
2. Executive Summary
2.1 Executive Summary
2.2 Key Highlights - Facts about the Morocco Healthcare Market
2.3 Key Highlights: Healthcare Startups in Morocco
2.4 Key Events: Morocco Healthcare Industry, 2015-2021
2.5 Key Events: Morocco Pharmaceutical Market
2.6 Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2020-2021
2.7 Key Events: Top Completed Deals by Value, 2020-2021
2.8 Country Profile, Morocco, 2020
3. Overview of Pharmaceutical Market
3.1 Pharmaceutical Market - Overview
3.2 Pharmaceutical Market - Exports
3.3 Pharmaceutical Market - Imports
3.4 Pharmaceutical Market - Supply Channels, Morocco
3.5 Pharmaceutical Market - Market Segments
3.6 Major Therapeutic Areas, Morocco
3.7 COVID-19 Epidemiology, Morocco
3.8 COVID-19 Impact and Developments, Government response to mitigate the impact of COVID-19 Morocco
3.9 COVID-19 Impact and Developments in the Healthcare Market, Morocco
3.10 COVID-19 Clinical Trials Landscape, Morocco
3.11 Pharmaceutical Market - Major Players
4. Overview of Medical Devices Market
4.1 Medical Device Market - Overview
4.2 Medical Devices Market - Major Players
5. Pharmaceutical and Medical Devices Market - Drivers and Barriers
5.1 Drivers
5.2 Barriers
6. Deal Analysis
6.1 Deal Analysis: Pharmaceutical Market, Morocco, 2019-2021
6.2 Deal Analysis: Medical Device Market, Morocco, 2020-2021
7. HealthTech Landscape
7.1 HealthTech Landscape, Morocco
7.2 HealthTech Deals Landscape, Morocco
7.3 Key HealthTech Deals, Morocco
7.4 Adoption of Technology in Healthcare, Morocco
7.5 Digital Health Regulations, Morocco
7.6 Digital Health: Benefits and Risks, Morocco
8. Market Access
8.1 Overview of Healthcare System, Morocco
8.2 Reimbursement Process, Morocco
8.3 Overview of Insurance Providers, Morocco
8.4 Out-of-Pocket Spending and Pharmaceutical Price Index, Morocco
8.5 Pricing Policies, Morocco
8.6 Regulatory Landscape, Morocco
8.6.1 Overview of Regulatory Agencies, Morocco
8.6.2 Marketing Authorization for Pharmaceutical Products, Morocco
8.6.3 Marketing Authorization for Biosimilars, Morocco
8.6.4 Marketing Authorization for Medical Devices, Morocco
8.6.5 Intellectual Property Rights, Patent, Morocco
8.6.6 Intellectual Property Rights, Trademark, Morocco
8.6.7 Clinical Trial Regulations, Morocco
8.6.8 Pharmaceutical Clinical Trials Landscape, Morocco
8.6.9 Medical Devices Clinical Trials Landscape, Morocco
8.6.10 Pharmacy License Regulations, Morocco
8.6.11 Pharmaceutical Advertising Regulations, Morocco
8.6.12 Labeling and Packaging Regulations, Morocco
9. Country Healthcare Landscape
9.1 Healthcare Policy Highlights, Morocco
9.2 Healthcare Facilities, Morocco
9.3 Life Expectancy and Immunization Rate, Morocco
9.4 Environmental Health, Morocco
9.5 Healthcare Personnel, Morocco
9.6 Disease Burden, Morocco
9.7 Healthcare Expenditure, Morocco
10. Trade Associations, Morocco
11. Trade Fairs, Morocco
12. Opportunities and Challenges
13. Appendix
13.1 Research Methodology
13.1.1 Coverage
13.1.2 Secondary Research
13.1.3 Forecasts
13.2 Bibliography
13.3 About GlobalData
13.4 Contact Us
13.5 Disclaimer

List of Tables
Table 1: List of Biosimilars Approved, Morocco, 2015-2019
Table 2: COVID-19 Indicators (Number of Cases), Morocco and Global, 2021
Table 3: COVID-19-Related Travel Restrictions, Morocco, 2020-2021
Table 4: Available COVID-19 Vaccines, Morocco, 2021
Table 5: Top COVID-19 Markets by Product Categories (Number of Available Marketed Products), Morocco, 2020-2021
Table 6: Legal Frameworks for e-Health, Morocco, 2019
Table 7: Patent Fees, Morocco, 2020
Table 8: Trademark Fees, Morocco, 2020
Table 9: Medical Devices Clinical Trials, Morocco, 2019-2021

List of Figures
Figure 1: Pharmaceutical Market, Morocco, Revenue ($B and MAD B), 2013-2020
Figure 2: Medical Device Market, Morocco, Revenue ($M), 2015-2020
Figure 3: Healthcare Start-Ups in Morocco, 2020
Figure 4: Country Profile, Morocco, 2020
Figure 5: Pharmaceutical Market, Morocco, Revenue ($B), 2015-2020
Figure 6: Pharmaceutical Market, Morocco, Revenue Forecast ($B), 2021-2025
Figure 7: Significant Events in the Evolution of the Pharmaceutical Industry, Morocco, 1960-2020
Figure 8: Pharmaceutical Exports ($M), Morocco, 2011-2020
Figure 9: Top Export Partners, Morocco, 2020
Figure 10: Pharmaceutical Imports ($M), Morocco, 2011-2020
Figure 11: Top Import Partners, Morocco, 2020
Figure 12: Pharmaceutical Distribution Channels, Morocco, 2019
Figure 13: Generics Market, Revenue (MAD B and $B), Morocco, 2015-2020
Figure 14: Generic Drug Consumption Volume (Millions of Units), Morocco, 2015-2020
Figure 15: OTC Market, Revenue (MAD M and $M), Morocco, 2015-2019
Figure 16: OTC Market, Million Number of Units, Morocco, 2016-2019
Figure 17: Biosimilars Market, Revenue (MAD M and $M), Morocco, 2015-2019
Figure 18: Major Pharmaceutical Products in the Market, Revenue in $M and MAD M), Morocco, 2019
Figure 19: Major Therapeutic Areas by Pharmaceutical Sales ($M), Morocco, 2017-2019
Figure 20: COVID-19 (Number of Cases), Morocco, 2020-2021
Figure 21: COVID-19 (Number of Deaths), Morocco, 2020-2021
Figure 22: COVID-19 Fiscal Stimulus Timeline, Morocco, 2020-2021
Figure 23: COVID-19 Vaccine Administration, Number of Vaccines administered, Morocco, 2021
Figure 24: Medical Devices Market, Morocco, Revenue ($M), 2013-2020
Figure 25: Medical Devices Market, Morocco, Revenue ($B) of Major Companies, 2020
Figure 26: Deal Value ($M), Pharmaceutical Market, Morocco, 2019-2021
Figure 27: Deal Value and Deal Count, Quarterly, Pharmaceutical Market, Morocco, 2019-2021
Figure 28: Deal Count, Pharmaceutical Market, Morocco, 2019-2021
Figure 29: Top Therapy Areas by Deal Value ($M), Pharmaceutical Market, Morocco, 2019-2021
Figure 30: Top Therapy Areas by Deal Count, Pharmaceutical Market, Morocco, 2019-2021
Figure 31: M&A Deals by Quarter, Pharmaceutical Market, Morocco, 2019-2021 (by Value and by Number)
Figure 32: M&A Deals, Medical Device Market, Morocco, 2020-2021 (by Value and by Number)
Figure 33: Deal Value and Deal Count, Quarterly, Medical Devices Market, Morocco, 2020-2021
Figure 34: Top Equipment Sectors, Medical Devices Market, Morocco, 2020-2021
(by Value and by Number)
Figure 35: Organizational Chart, National Commission for the Protection of Personal Data (CNDP), Morocco, 2021
Figure 36: Moroccan Patient-Centered Health Information System - Global Architecture, 2019
Figure 37: Deal Count (Number of Deals), HealthTech, Morocco, 2019-2021
Figure 38: Organization of Healthcare System, Morocco, 2019
Figure 39: Number of Drugs Reimbursable by the Compulsory Health Insurance (AMO) Morocco, 2011-2020
Figure 40: Reimbursement Process, Morocco, 2019
Figure 41: Distribution of Population across Health Insurance Schemes, Morocco, 2016
Figure 42: Out-of-Pocket Spending ($ per Capita), Morocco, 2011-2020
Figure 43: Change in Pharmaceutical Price Index (% Change Accumulated in the Year), Morocco, 2014-2020
Figure 44: Organizational Structure, Ministry of Health, Morocco, 2019
Figure 45: Marketing Authorization of Pharmaceutical Products, Morocco, 2020
Figure 46: Marketing Authorization of Biosimilars, Morocco, 2020
Figure 47: Patent Approval Process, Morocco, 2020
Figure 48: Trademark Approval Process, Morocco, 2020
Figure 49: Clinical Trial Approval Process, Morocco, 2020
Figure 50: Pharmaceutical Clinical Trials Count by Trial Status, Morocco, 2019-2021
Figure 51: Pharmaceutical Clinical Trials Count by Phase, Morocco, 2019-2021
Figure 52: Pharmaceutical Clinical Trials Count by Indication, Morocco, 2019-2021
Figure 53: Pharmaceutical Clinical trials by Trial Sponsors, Morocco, 2019-2021
Figure 54: Pharmacy Regulations, Morocco, 2019
Figure 55: Labelling and Packaging, Morocco, 2019
Figure 56: Number of Public Hospitals, Morocco, 2013-2020
Figure 57: Hospital Beds Density (per 10,000 Population), Morocco, 2013-2020
Figure 58: Life Expectancy at Birth (Years), Morocco, 2013-2020
Figure 59: Immunization Rate (% of Children Ages 12-23 Months), Morocco, 2013-2019
Figure 60: PM2.5 (µg per m3), Morocco, 2012-2020
Figure 61: CO2 Emissions (Mt of CO2), Morocco, 2012-2020
Figure 62: Number of Physicians, Morocco, 2013-2020
Figure 63: Number of Nurses, Morocco, 2013-2020
Figure 64: Number of Dentists, Morocco, 2013-2020
Figure 65: Number of Pharmacists, Morocco, 2013-2020
Figure 66: Major Causes of Mortality (per 100,000 population), Morocco, 2019
Figure 67: Major Causes of Male Mortality (per 100,000 population), Morocco, 2019
Figure 68: Major Causes of Female Mortality (per 100,000 population), Morocco, 2019
Figure 69: Disability-Adjusted Life Years by Major Disease (per 100,000 population), Morocco, 2019
Figure 70: Healthcare Expenditure as Percentage of GDP (%), Morocco, 2012-2020
Figure 71: Health Expenditure Share (% of Health Spending), Morocco, 2012-2020
Figure 72: Opportunities and Challenges

Filed in: Pharmaceutical

Publisher : GlobalData

Name:
Email:
Phone:
Subject:
Comments:

More Reports

Title	Price	Buy Now
Ambulatory EHR Market by Delivery Mode (Cloud-based, On-premise), Application (e-Prescribing, PHM, Health Analytics, Practice, Patient & Referral Management), Practice Size (Large, Small-to-Medium, Solo), End User (Independent) – Global Forecast to 2027 “The ambulatory EHR market is projected to grow at a CAGR of 6.1% between 2022 and 2027.” The global ambulatory EHR market is projected to reach USD 5.7 billion in 2022 to USD 7.7 billion by 2027, at a CAGR of 6.1%during the forecast period. Growth in this market is driven by the opportunities provided by the market such as increasing demand for cloud-based ambulatory EHR market, and shift towards patient-centric healthcare delivery. However, the interoperability issues & data security concerns are some of the challenges that are expected to limit the growth of the market to a certain extent during the forecast period. “Cloud-based was the fastest-growing segment in the delivery mode of ambulatory EHR market in 2021” Cloud-based segment is projected to growth at the hi......	$4950
Pharmaceutical Excipients Market by Product (Organic Chemicals (Carbohydrates), Inorganic Chemicals (Calcium Phosphate)), Functionality (Fillers, Binders, Lubricants, Preservatives), Formulation (Tablets, Capsules, Parenteral) – Global Forecast to 2027 “The pharmaceutical excipients market growth can be attributed to factors such as the rising pharmaceuticals market, advancements in functional excipients, and the growing generics market. The rapidly growing biopharmaceuticals sector will also influence market growth..” The pharmaceutical excipients market is projected to reach USD 11.5 Billion by 2027 from USD 8.6 Billion in 2022, at a CAGR of 5.9% during the forecast period.The growth can be attributed to the expanding pharmaceutical industry which has fueled the drug production thereby increasing consumption rate for excipients. Additionally, factors like functional excipients development and upsurge in generics market is also likely to propel market growth. “The fillers & diluents functionality accounted for the larges......	$
Digital Pharmacy Market by Drug (Rx, OTC), Product (Medicine, Personal Care, Vitamins & Supplements, Diabetes, CVD, Oncology), Platform (Apps, Websites), Business Model (Captive, Franchise, Aggregator), Geographic (Urban, Rural) – Global Forecasts to 2027 “Digital Pharmacy market to register a CAGR of 17.0% during the forecasts period The digital pharmacy market is expected to reach USD 211.9 billion by 2027 from USD 96.5 billion in 2022, at a CAGR of 17.0% during the forecast period. The growth of this market is driven by the growing consumer preference toward buying online medicines during and post COVID-19 pandemic, consolidation in the market and partnerships, and increasing geriatric population. However, patients relying on pharmacists for clinical support and increasing number of illegal pharmacies are expected to restrain the growth of this market during the forecast period. “Over-the-counter (OTC) products segment is estimated to grow at the highest rate during the forecast period” On the basis ofdrug type, t......	$4950
Pharmacy Automation Market by Product (Automated Medication Dispensing & Storage Systems, Table-Top Counters, Retrieval Systems, Medication Compounding), End User (Inpatient, Outpatient (Fast-Track Clinics), Retail Pharmacies) – Global Forecast to 2027 The pharmacy automation market is expected to grow at a CAGR of 7.9% in the forecast period. The pharmacy automation market is projected to reach USD 8.2 billion by 2027 from USD 5.6 billion in 2022, at a CAGR of 7.9% during the forecast period. The growth in this market is attributed to the growing need to minimize medication errors, rapid decentralization of pharmacies, and growing focus on automation to reduce labor costs. However, the stringent regulations that delay product launches can inhibit the growth of this market. Based on product, the automated medication dispensing and storage systems segment holds the largest market share in 2021 Based on products, the pharmacy automation market is segmented into automated medication dispensing and storage systems, automated packagi......	$4950
Topical Drug Delivery Market by Type (Semi-solids (Creams, Gels, Lotions), Solids(Suppositories), Liquids(Solutions), Transdermal products), Route(Dermal, Ophthalmic), Facility of Use (Homecare setting, Hospitals, Burn Centres) – Global Forecast to 2027 The topical drug delivery market is expected to grow at a CAGR of 8.9% in the forecast period. The global topical drug delivery market is projected to reach USD 317.8 billion by 2027 from USD 207.4 billion in 2022, at a CAGR of 8.9%. The growth of this market can largely be attributed to the high prevalence of topical prescription therapy for dry eye diseases, growing focus of pharmaceutical companies on the R&D of smart transdermal drug delivery systems, increase in prevalence of central nervous disorders, rising preference for non-invasive drug delivery methods. “The semi-solid formulation segment accounted for the largest share of the topical drug delivery market, based on product in 2021.” Based on products, the topical drug delivery the market is segmented into ......	$4950
Cognition and Memory Enhancement Market by Product & Service (Cognition & Memory-enhancing Drugs, Brain-boosting Nutraceuticals, Cognitive Assessment & Training Solutions), Region (North America, Europe, Asia Pacific, ROW) – Global Forecast to 2026 “Increasing incidence and prevalence of neurological disorders is a key factors driving growth in the cognition and memory enhancement market’’ The global cognition and memory enhancement market is projected to reach USD 38.9 billion by 2026 from USD 23.4 billion in 2021, at a CAGR of 10.7% during the forecast period. Elevating prevalence of neurological disorders, such as dementia, epilepsy, Parkinson’s disease, Huntington’s disease, headache disorders, multiple sclerosis, neuroinfections, stroke, and cerebral palsy, have increased significantly over the years. “By product & service segment, the cognition & memory-enhancing drugs segment has registered fastest growth rate during the forecast period” Based on product & service, the cognition and memory en......	$4950
High Potency APIs/HPAPI Market by Type (Innovative, Generic), Type of Synthesis (Synthetic, Biotech, Biosimilars, mAbs, Vaccines), Manufacturers (Captive, Merchant), Application (Oncology, Hormonal Imbalance, Glaucoma) Region – Global forecast to 2027 The HPAPI market is projected to reach USD 39.6 Billion by 2027 from USD 24.5 billion in 2022, at a CAGR of 10.1% from 2022 to 2027. The market is driven by increasing demand for oncology drugs, growing demand for antibody-drug conjugates and others. “The innovative HPAPIs segment is expected to account for the largest share of the market in 2021” Based on type, the HPAPI market is segmented into innovative and generic. The innovative segment is expected to account for the largest share of the HPAPI market in 2021. The large share can be attributed to the increased R&D investments. “The Synthetic APIs segment to account for the largest share of the market in 2021” Based on type of synthesis, the market is segmented into synthetic and biotech HPAPIs. The synthetic AP......	$4950
Plasma Fractionation Market by Product (Immunoglobulins, Albumin, Protease Inhibitors, von Willebrand Factor, PCC), Application (Neurology, Immunology, Hematology, Rheumatology), End User (Clinical Research, Hospitals & Clinics) – Global Forecast to 2027 “Increased risk of communicable diseases, Rising prevalence of bleeding disorders in global population, Use of Immunoglobulin’s for a range of neurological conditions, including multiple sclerosis, neuropathic pain, and chronic fatigue syndrome is expected to drive the overall growth of the plasma fractionation market.” The global plasma fractionation market size is projected to reach USD 36.7 billion by 2027 from USD 26.5 billion in 2022, at a CAGR of 6.7% during the forecast period. Market growth is driven mainly by factors such as rapid growth of geriatric population, growing prevalence of respiratory disorders such as alpha-1-antitrypsin deficiency (AATD) and emphysema, and use of plasma fractionation products as first-line therapies for a number of bleeding, hematological, an......	$4950
Patient Engagement Solutions Market by Component (Software, Services), Delivery (On-Premise, Cloud), Therapy Area (CVD, Diabetes, Obesity, Fitness), Functionality (E-prescribing, Virtual care), End User (Provider, Payer, Patients) – Global Forecast to 2027 “Patient engagement solutions market to register a CAGR of 10.0% from 2022 to 2027” The patient engagement solutions market is projected to reach USD 27.9 billion by 2027 from USD 17.3 billion in 2022, at a CAGR of 10.0% during the forecast period. The growth of this market is driven by the adoption and changes in government regulations to promote patient-centric care and involve patients throughout the care journey, high demand for patient engagement solutions, and the growing utilization of m- health apps. However, interoperability issues for patient engagement solutions and a dreadth of skilled IT professionals in the healthcare industry are expected to restrain the growth of this market during the forecast period. “Services segment is expected to grow at the highest rate......	$4950
Healthcare Cloud Computing Market by Product (EMR/EHR, VNA, RIS, LIS, PIS), Deployment (Private Cloud, Hybrid Cloud, Public Cloud), Component (Software, Services), Pricing (Spot Pricing), Service (SaaS, IaaS, PaaS), End User – Global Forecasts to 2027 The global Healthcare cloud computing market is projected to reach USD 89.4 billion by 2027 from USD 39.4 billion in 2022, at a CAGR of 17.8%. The factors driving the market are adoption of technologies like telehealth, EHR, big data analytics, IoT, cloud computing, m health, wearlable devices, etc. “The healthcare provider solution was the largest segment in the healthcare cloud computing market in 2021.” The healthcare provider segment accounted for the larger share of 79.2% of the healthcare cloud computing market in 2021. The growing adoption of various health IT solutions such as EHR, e-prescribing, telehealth, mHealth, and others due to COVID-19 is one of the key factors contributing to the growth of this segment. “Among end users, the healthcare providers segment ac......	$4950

Morocco - Healthcare, Regulatory and Reimbursement Landscape

Benefits of Sandler Research

User License for Reports

Reach Us

Contact Us

Knowledge Store

Email Subscription

our Feed Reader

Ambulatory EHR Market by Delivery Mode (Cloud-based, On-premise), Application (e-Prescribing, PHM, Health Analytics, Practice, Patient & Referral Management), Practice Size (Large, Small-to-Medium, Solo), End User (Independent) – Global Forecast to 2027

Pharmaceutical Excipients Market by Product (Organic Chemicals (Carbohydrates), Inorganic Chemicals (Calcium Phosphate)), Functionality (Fillers, Binders, Lubricants, Preservatives), Formulation (Tablets, Capsules, Parenteral) – Global Forecast to 2027

Digital Pharmacy Market by Drug (Rx, OTC), Product (Medicine, Personal Care, Vitamins & Supplements, Diabetes, CVD, Oncology), Platform (Apps, Websites), Business Model (Captive, Franchise, Aggregator), Geographic (Urban, Rural) – Global Forecasts to 2027

Pharmacy Automation Market by Product (Automated Medication Dispensing & Storage Systems, Table-Top Counters, Retrieval Systems, Medication Compounding), End User (Inpatient, Outpatient (Fast-Track Clinics), Retail Pharmacies) – Global Forecast to 2027

Topical Drug Delivery Market by Type (Semi-solids (Creams, Gels, Lotions), Solids(Suppositories), Liquids(Solutions), Transdermal products), Route(Dermal, Ophthalmic), Facility of Use (Homecare setting, Hospitals, Burn Centres) – Global Forecast to 2027

Cognition and Memory Enhancement Market by Product & Service (Cognition & Memory-enhancing Drugs, Brain-boosting Nutraceuticals, Cognitive Assessment & Training Solutions), Region (North America, Europe, Asia Pacific, ROW) – Global Forecast to 2026

High Potency APIs/HPAPI Market by Type (Innovative, Generic), Type of Synthesis (Synthetic, Biotech, Biosimilars, mAbs, Vaccines), Manufacturers (Captive, Merchant), Application (Oncology, Hormonal Imbalance, Glaucoma) Region – Global forecast to 2027

Plasma Fractionation Market by Product (Immunoglobulins, Albumin, Protease Inhibitors, von Willebrand Factor, PCC), Application (Neurology, Immunology, Hematology, Rheumatology), End User (Clinical Research, Hospitals & Clinics) – Global Forecast to 2027

Patient Engagement Solutions Market by Component (Software, Services), Delivery (On-Premise, Cloud), Therapy Area (CVD, Diabetes, Obesity, Fitness), Functionality (E-prescribing, Virtual care), End User (Provider, Payer, Patients) – Global Forecast to 2027

Healthcare Cloud Computing Market by Product (EMR/EHR, VNA, RIS, LIS, PIS), Deployment (Private Cloud, Hybrid Cloud, Public Cloud), Component (Software, Services), Pricing (Spot Pricing), Service (SaaS, IaaS, PaaS), End User – Global Forecasts to 2027